Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GRIMAUDO, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.686
EU - Europa 5.537
AS - Asia 4.619
SA - Sud America 737
AF - Africa 140
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 9
Totale 21.754
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.537
SG - Singapore 1.707
RU - Federazione Russa 1.479
IT - Italia 1.316
CN - Cina 1.197
FI - Finlandia 594
BR - Brasile 590
DE - Germania 495
HK - Hong Kong 478
VN - Vietnam 427
UA - Ucraina 383
PL - Polonia 267
GB - Regno Unito 227
FR - Francia 203
IE - Irlanda 179
JP - Giappone 156
IN - India 144
KR - Corea 117
SE - Svezia 117
BD - Bangladesh 74
CA - Canada 67
AR - Argentina 62
IQ - Iraq 54
NL - Olanda 49
RO - Romania 49
MX - Messico 45
TR - Turchia 43
AT - Austria 33
CI - Costa d'Avorio 33
ID - Indonesia 32
BE - Belgio 29
ES - Italia 28
ZA - Sudafrica 28
AU - Australia 23
PK - Pakistan 23
UZ - Uzbekistan 22
SA - Arabia Saudita 21
IR - Iran 20
EC - Ecuador 19
MA - Marocco 19
CL - Cile 16
GR - Grecia 16
JO - Giordania 15
PH - Filippine 14
JM - Giamaica 12
LT - Lituania 12
TN - Tunisia 12
VE - Venezuela 12
CO - Colombia 11
SK - Slovacchia (Repubblica Slovacca) 11
MY - Malesia 10
AZ - Azerbaigian 9
EG - Egitto 9
PY - Paraguay 9
PE - Perù 8
BG - Bulgaria 7
BO - Bolivia 7
CH - Svizzera 7
BY - Bielorussia 6
DK - Danimarca 6
DZ - Algeria 6
KE - Kenya 6
LB - Libano 6
NP - Nepal 6
PA - Panama 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
HN - Honduras 5
KZ - Kazakistan 5
NG - Nigeria 5
OM - Oman 5
SN - Senegal 5
AO - Angola 4
GA - Gabon 4
NI - Nicaragua 4
PT - Portogallo 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EU - Europa 3
GE - Georgia 3
KG - Kirghizistan 3
KH - Cambogia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CY - Cipro 2
ET - Etiopia 2
IL - Israele 2
LU - Lussemburgo 2
MD - Moldavia 2
NO - Norvegia 2
RE - Reunion 2
TH - Thailandia 2
UY - Uruguay 2
BJ - Benin 1
BN - Brunei Darussalam 1
Totale 21.736
Salva come PNG Salva come JPEG
Città #
Ashburn 1.407
Fairfield 1.327
Singapore 1.210
Woodbridge 669
Chandler 606
Houston 542
Seattle 527
Wilmington 501
Hong Kong 451
San Jose 451
Cambridge 419
Ann Arbor 380
Palermo 370
Moscow 264
Zgierz 231
Beijing 189
Des Moines 173
Dublin 173
Jacksonville 172
Medford 166
Los Angeles 162
Ho Chi Minh City 155
Tokyo 144
New York 143
Santa Clara 143
Frankfurt am Main 139
Helsinki 125
Dallas 120
Altamura 116
The Dalles 116
Nanjing 115
Hanoi 114
Council Bluffs 113
Princeton 109
Lauterbourg 108
Hefei 90
Lawrence 90
Rome 72
San Diego 71
Boardman 65
Buffalo 60
Milan 60
Chicago 58
Tulsa 50
London 48
Orem 47
São Paulo 46
Dearborn 42
Shenyang 42
Jinan 41
Seoul 39
Nanchang 34
Tianjin 34
Abidjan 33
Changsha 32
Chennai 29
Jiaxing 28
Nuremberg 28
Stockholm 28
Brussels 27
Hebei 27
Ludwigshafen am Rhein 27
Guangzhou 26
Mumbai 25
Warsaw 25
Atlanta 24
San Paolo di Civitate 24
Zhengzhou 24
Baghdad 23
Montreal 23
Ningbo 23
Phoenix 23
Saint Petersburg 23
Washington 23
Amsterdam 20
Denver 20
Johannesburg 20
Brooklyn 19
Belo Horizonte 17
Columbus 17
Kumar 17
Poplar 17
Porto Alegre 16
Redondo Beach 16
Seongnam 16
Tashkent 16
Amman 15
Boston 15
Haiphong 15
Da Nang 14
Falls Church 14
Hangzhou 14
Izmir 14
Manchester 14
San Mateo 14
Shanghai 14
Athens 13
Bremen 13
Haikou 13
Taizhou 13
Totale 14.090
Salva come PNG Salva come JPEG
Nome #
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis 387
Heterocyclic and Phenyl Double-Bond-Locked Combretastatin Analogues Possessing Potent Apoptosis-inducing activity in HL60 and in MDR Cell lines 355
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 313
Stilbene-based anticancer agents: Resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism. 310
Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells 299
Clinical course and genetic susceptibility of primary biliary cirrhosis: Analysis of a prospective cohort 299
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease 298
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 295
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 286
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 284
Studies on the apoptotic activity of natural and synthetic retinoids: discovery of a new class of synthetic terphenyls that potently support cell growth and inhibit apoptosis in neuronal and HL-60 cells 277
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells 271
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 269
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors 252
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 251
The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients. 250
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. 245
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis 244
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 239
MAFLD: a multisystem disease 238
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease 237
Synthesis and antiproliferative activity of 3-(2-cloroethyl)-5-methyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-(3H)-one 236
Effects of Pimozide Derivatives on pSTAT5 in K562 Cells 231
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives 230
Flusso di informazione nella materia vivente 229
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. 226
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. 226
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 226
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells 225
Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[2E]-3-phenylprop-2-enoylamino}benzamides 224
SYNTHESIS AND ANTIPROLIFERATIVE ACTIVITY OF 3-AMINO-N-PHENYL-1H-INDAZOLE-1-CARBOXAMIDES 222
Antiproliferative Agents That Interfere with the Cell Cycle at the G(1)-->S Transition: Further Development and Characterization of a Small Library of Stilbene-Derived Compounds 220
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity 218
Effetti antileucemici di due stilbeni identificati in uve provenienti da vigneti affetti da peronospora e Botrytis cinerea 217
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C 213
The "Janus" Role of C/EBPs Family Members in Cancer Progression 213
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. 211
Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization. 210
The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells. 210
Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 210
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 209
Effects of Propolis in cancer cells 208
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides 207
Genetic predisposition to thrombophilia in inflammatory bowel disease 204
Identification of biphenyl-based hybrid molecules able to decrease the intracellular level of Bcl-2 protein in Bcl-2 overexpressing leukemia cells. 203
Substituted 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]thiophene derivatives as potent tubulin polymerization inhibitors 202
Optimizing sequential systemic therapies for advanced hepatocellular carcinoma: A decision analysis 202
Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity 198
Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C 195
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 195
Statin use and non-alcoholic steatohepatitis in at risk individuals 192
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 190
Superficial venous thrombosis: Prevalence of common genetic risk factors and their role on spreading to deep veins 186
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors. 183
Design, synthesis, and biological evaluation of thiophene analogues of chalcones 183
Synthesis and Biological Evaluation of 2- and 3-Aminobenzo[b]thiophene Derivatives as Antimitotic Agents and Inhibitors of Tubulin Polymerization. 182
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 182
Induction of differentiation by phenols crude extract of extravirgin olive oil on tumor cell lines sensitive and resistatnt to antitumor agents 181
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 181
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C 180
Methylenetetrahydrofolate reductase mutation in subjects with abdominal aortic aneurysm subdivided for age. 179
Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy 179
Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms 178
A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis 178
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease 177
Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis 175
“Effects of combretastatin analogues on leukemic cell lines and normal hemopoietic cells” 175
Novel Terphenyls and 3,5-Diaryl Isoxazole Derivatives Endowed with Growth Supporting and Antiapoptotic Properties 173
Synthesis and Biological Evaluation of 1-Methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a New Class of Antimitotic Agents and Tubulin Inhibitors 170
Trombosi portale mesenterica idiopatica in paziente con doppia mutazione eterozigote del gene C677T e del gene A1298C della MTHFR 162
EPIGENETIC PROFILING AND THERAPEUTICS IN LIVER DISEASE 160
IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. 159
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 159
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis 159
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction 156
Effects of phenols of extra virgin olive oil on HL60 cell lines sensitive and reristant to anthracyclines 156
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease 156
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 156
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 155
Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line 151
The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis 150
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease 149
Effects of phenols of extra vergin olive oil on Hl60 cell lines sensitive and resistant to anthracycline 148
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV 146
SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study 146
GENOTYPIC AND PHENOTIPIC FACTORS IN ISCHEMIC STROKE IN YOUNG ADULTS 145
The PD-1/PD-L1 Axis in the Biology of MASLD 142
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease 140
Synthesis and anticancer activity of 3-amino-N-phenyl-1H-indazole-1-carboxamide and 1-(1H)indazol-3-yl-3-phenylureido derivatives 140
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 140
PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19 139
MTHFR allele 677T and risk of abdominal aortic aneurysm 135
Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19, (S0168827823051474), (10.1016/j.jhep.2023.09.020)] 134
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-N,N-dimethylamino benzo[b]furan derivatives as inhibitors of tubulin polymerization 134
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivatives. 134
Synthesis and antiproliferative activities of two new analogs of tetrazepinones 127
In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C 124
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease 124
Induction of differentiation by phenols crude extract of extavirgin olive oil on tumor cell lines sensitive and resistant to anticancer drugs 122
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization 120
Totale 20.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.468
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021330 0 0 0 0 0 0 0 0 0 0 174 156
2021/20221.414 105 293 42 58 38 45 77 95 161 163 105 232
2022/20231.885 184 376 31 189 193 294 140 131 213 12 78 44
2023/2024868 35 104 44 66 104 211 70 76 8 32 34 84
2024/20252.347 68 112 146 238 81 84 235 145 171 267 337 463
2025/20268.234 674 250 495 696 833 1.258 1.258 883 626 976 285 0
Totale 22.269